Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CUSKIN is a South Korean cosmeceutical skincare company focused on dermatologist-informed products for clinics, esthetics, and consumer skincare. The company describes itself as specializing in clinic-grade and medical skincare developed in collaboration with dermatologists and skincare experts, with in-house R&D and production capabilities. Its portfolio appears centered on topical skin-health products for sensitive, aging, acne-prone, and post-treatment skin, including products featuring its patented Vitamin U ingredient as well as PDRN, bakuchiol, niacinamide, and other active ingredients. CUSKIN operates as a commercial-stage skincare and cosmetics business rather than a therapeutic drug developer, so it does not have a conventional biotech clinical pipeline. The brand also markets in the United States through CUSKIN USA and emphasizes Made-in-Korea manufacturing and cosmeceutical positioning.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CUSKIN.